Innovent Biologics (HKEX: 01801) has formed a strategic partnership with ASK Pharm (SZ: 002755) to commercialize limertinib, ...
Zacks.com on MSN3h
Regeneron Gains 13.5% Year to date: How to Play the Stock?Shares of Regeneron Pharmaceuticals, Inc. REGN have gained 13.5% in the year so far against the industry’s decline of 2.8%.
Potential new benefit for home health care for seniors to be funded through Medicare drug price negotiations, likely ...
Attorney General Bridget Hill announced a settlement with Sanofi-Aventis U.S. LLC (Sanofi), which guarantees that Wyoming ...
Nurix Therapeutics offers promising targeted protein degradation treatments for cancer and autoimmune diseases. Find out what ...
Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.
Global immunotherapy drugs market is valued at approximately USD 247.44 billion in 2023 and is projected to grow at a healthy CAGR of 15.3% over the forecast period 2024-2032. Request To Download Free ...
Westside Current on MSN21h
Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung CancerInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
Researchers hope to plan clinical trials of 5-fluorouracil with drugs that would enhance its RNA-damaging effects and kill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback